Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mineralocorticoid Receptor Blocker Eplerenone Improves Endothelial Function and Inhibits Rho-Associated Kinase Activity in Patients With Hypertension

Published:2011-12-28 Issue:2 Volume:91 Page:289-297
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:
Short-container-title:Clin Pharmacol Ther

Author:

Fujimura N,Noma K,Hata T,Soga J,Hidaka T,Idei N,Fujii Y,Mikami S,Maruhashi T,Iwamoto Y,Kihara Y,Chayama K,Kato H,Liao J K,Higashi Y

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference47 articles.

1. Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-Kinase

2. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

3. Rho GTPases and the Actin Cytoskeleton

4. Regulation of the Association of Adducin with Actin Filaments by Rho-associated Kinase (Rho-kinase) and Myosin Phosphatase

5. Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth Muscle

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histamine H2-receptor antagonism improves conduit artery endothelial function and reduces plasma aldosterone level without lowering arterial blood pressure in angiotensin II–hypertensive mice;Pflügers Archiv - European Journal of Physiology;2024-01-27

2. Smoking cessation and vascular endothelial function;Hypertension Research;2023-10-12

3. Cardiovascular risk in patients receiving antihypertensive drug treatment from the perspective of endothelial function;Hypertension Research;2022-05-20

4. Comparative Efficacy of Antihypertensive Agents in Flow-Mediated Vasodilation of Patients with Hypertension: Network Meta-Analysis of Randomized Controlled Trial;International Journal of Hypertension;2022-04-30

5. Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight;International Journal of Molecular Sciences;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3